BioRestorative Therapies EPS BRTX
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Mar 31, 2026
- −$21.60
- Latest quarter, Q1 FY26
- −$2.40
- Fiscal year 2025
- −$32.00
BioRestorative Therapies' earnings per share was −$21.60 over the twelve months to Mar 31, 2026.
In its latest quarter, Q1 FY26, it was −$2.40.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$32.00 | n/a |
| FY2024 | −$23.20 | n/a |
| FY2023 | −$70.00 | n/a |
| FY2022 | −$102.40 | n/a |
| FY2021 | −$1071.80 | n/a |
| FY2020 | −$1055.40 | n/a |
| FY2019 | −$63200.00 | n/a |
| FY2018 | −$132800.00 | n/a |
| FY2017 | −$141600.00 | n/a |
| FY2016 | −$170400.00 | n/a |
| FY2015 | −$258400.00 | n/a |
| FY2014 | −$360800.00 | n/a |
| FY2013 | −$560000.00 | n/a |
| FY2012 | −$576000.00 | n/a |
| FY2011 | $0.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q1 FY26 | −$2.40 | n/a | −$21.60 | |
| Q4 FY25 | −$6.60 | n/a | −$32.00 | |
| Q3 FY25 | −$6.60 | n/a | −$29.40 | |
| Q2 FY25 | −$6.00 | n/a | −$25.40 | |
| Q1 FY25 | −$12.80 | n/a | −$29.40 | |
| Q4 FY24 | −$4.00 | n/a | −$23.20 | |
| Q3 FY24 | −$2.60 | −133% | −$29.00 | |
| Q2 FY24 | −$10.00 | n/a | −$18.60 | |
| Q1 FY24 | −$6.60 | n/a | −$38.00 | |
| Q4 FY23 | −$9.80 | n/a | −$70.00 | |
| Q3 FY23 | $7.80 | n/a | −$84.00 | |
| Q2 FY23 | −$29.40 | n/a | −$117.40 |
Against its peers
Companies in Healthcare nearest BioRestorative Therapies' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| BRTXBioRestorative Therapies | −$21.60 | |
| OXBROXBRIDGE RE HOLDINGS | $0.02 | |
| EDUCEducational Development | $0.19 | |
| GTIMGood Times Restaurants | $0.21 | +75% a year |
| MDRRMedalist Diversified | $3.84 | |
| BCGBinah Capital | $0.16 | |
| VIPVulcan Infrastructure & Power | $0.07 | |
| MXCMexco Energy | $0.75 | −5% a year |
| Peer median | $0.19 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on BioRestorative Therapies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.